Latest content

  • How Immunocore tackles formulation development and delivery challenges for novel bispecifics26:58

    How Immunocore tackles formulation development and delivery challenges for novel bispecifics

    Watch this webinar about approaches and insights into bispecific formulation development and screening with Prometheus Panta for thermal and colloidal stability characterization of biotherapeutics.

    Watch
  • NanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market

    NanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market

    NanoTemper Technologies has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper...

    Read
  • How Pierre Fabre Laboratories enhances their antibody developability platform

    How Pierre Fabre Laboratories enhances their antibody developability platform

    Learn how Pierre Fabre uses multi-parameter stability measurements of mAb libraries on Prometheus Panta to streamline developability platforms, reducing complexity, cost, and sample consumption.

    Read
  • Optimization of membrane proteins for cryo-EM: Screening of copolymer nanodiscs with Prometheus Panta

    Optimization of membrane proteins for cryo-EM: Screening of copolymer nanodiscs with Prometheus Panta

    Membrane proteins present challenges for structural analysis by cryo-EM; Screening of synthetic copolymers with nanoDSF and DLS on Prometheus Panta help select the best solubilization conditions.

    Read
  • Why Dr. Elsa Wagner from Pierre Fabre chose Prometheus Panta for mAbs developability assessment

    Why Dr. Elsa Wagner from Pierre Fabre chose Prometheus Panta for mAbs developability assessment

    Read why scientist Dr. Elsa Wagner chose the Prometheus Panta instrument with simultaneous measurements of DLS, nanoDSF, SLS and backreflection for developability assessment of their mAbs candidates.

    Read
  • Fragment Screening: Save time and sample with Spectral Shift technology18:36

    Fragment Screening: Save time and sample with Spectral Shift technology

    Many methods used in fragment-based drug discovery pose real challenges — SPR often struggles to detect true hits due to fragments’ small mass, DSF can have high rates of false positives, and NMR equi

    Watch
  • ×

    Sign up to receive
    the latest NanoTemper news, product updates, event announcements and more

    First Name
    Last Name
    Company Name
    Country
    State
    Province
    State
    Region
    State
    Canton
    Agree to Subscribe & Privacy Policy*
    *I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

    By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
    Thank you!
    Error - something went wrong!
  • NanoTemper Technologies Establishes Advisory Board to Propel Innovation and Growth

    NanoTemper Technologies Establishes Advisory Board to Propel Innovation and Growth

    NanoTemper Technologies has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper...

    Read
  • De-risk your antibody characterization workflows with high-quality, multi-parameter stability data from Prometheus Panta16:24

    De-risk your antibody characterization workflows with high-quality, multi-parameter stability data from Prometheus Panta

    Get developability profiles for monoclonal antibodies with stability data from Prometheus Panta to inform on rational design and selection of therapeutic constructs that will succeed in the clinic.

    Watch
  • NanoTemper brings Spectral Shift technology to the protein production market with Andromeda X, enabling biopharma and CROs

    NanoTemper brings Spectral Shift technology to the protein production market with Andromeda X, enabling biopharma and CROs

    NanoTemper Technologies, well known for creating biophysical tools that accelerate the work of drug discovery researchers, brings their groundbreaking Spectral Shift technology to the protein...

    Read
  • Contact Specialist
  • 5 considerations for buffer optimization during biologics pre-formulation

    5 considerations for buffer optimization during biologics pre-formulation

    The work of pre-formulations scientists is critical to de-risk the entire development process for biologics. Read on to learn more about what to consider about your buffer components for...

    Read
  • 5 types of formulation excipients and how they impact biologics stability

    5 types of formulation excipients and how they impact biologics stability

    Each excipient class helps stabilize biologics – from monoclonal antibodies to vaccine antigens – in different ways. Read on to learn more about some of the most important excipients for...

    Read
  • Biologics Formulation: Select optimal buffer conditions with multi-parameter stability characterization from Prometheus Panta22:59

    Biologics Formulation: Select optimal buffer conditions with multi-parameter stability characterization from Prometheus Panta

    Learn how to identify optimal buffer conditions during pre-formulation, with multi-parameter stability characterization from Prometheus Panta, a tool to collect thermal and colloidal data while saving

    Watch
  • Measure the strength of any interaction with versatile labeling options for Spectral Shift

    Measure the strength of any interaction with versatile labeling options for Spectral Shift

    Read
  • How biologics teams use Dynamic Light Scattering to identify leading candidates13:12

    How biologics teams use Dynamic Light Scattering to identify leading candidates

    Watch this 15 min video to learn how groups in early biologics development and formulation use Dynamic Light Scattering (DLS) to make informed decisions that de-risk downstream biologics development.

    Watch
  • Virtual Monolith X Demo: Free-in-solution affinity measurements with minimal sample consumption​15:19

    Virtual Monolith X Demo: Free-in-solution affinity measurements with minimal sample consumption​

    The tool you choose to measure affinities should tackle a diverse range of targets and ligands that come your way — such as GPCRs, IDPs, or cancer-related proteins. And, you should get data that help

    Watch
  • Three things we took away from attending Drug Discovery Chemistry in 2024

    Three things we took away from attending Drug Discovery Chemistry in 2024

    Drug Discovery Chemistry is an annual event that focuses solely on early drug discovery, where scientists from around the world gather to showcase their research and participate in thoughtful...

    Read
  • Virtual Prometheus Panta demo: Four integrated technologies for protein stability characterization9:42

    Virtual Prometheus Panta demo: Four integrated technologies for protein stability characterization

    Your protein stability characterization projects require tools that provide high-precision, high-quality data to support your selection process. Watch this 10 min walkthrough of Prometheus Panta.

    Watch
  • Get predictive insight into your ADC’s stability with these 3 experiments

    Get predictive insight into your ADC’s stability with these 3 experiments

    Learn how it’s possible to use the Prometheus Panta to extrapolate how your low concentration sample will behave once it’s scaled up and at higher concentrations used for clinical administration.

    Read
  • Assess the impact of bioconjugation with multi-parameter stability characterization17:08

    Assess the impact of bioconjugation with multi-parameter stability characterization

    Characterize the developability of antibody-drug conjugates: Multi-parameter stability assessment with Prometheus Panta makes it possible to examine multiple aspects of ADC stability in parallel.

    Watch
  • What are ADCs and how do they work against cancer?0:40

    What are ADCs and how do they work against cancer?

    In this short animated video, learn the basics of how antibody-drug conjugates (ADCs) are engineered and why that makes them such powerful tools to target cancers with precision.

    Watch
  • loading
    Loading more...